{"id":13103,"date":"2009-01-15T20:00:00","date_gmt":"2009-01-15T20:00:00","guid":{"rendered":""},"modified":"2009-01-15T20:00:00","modified_gmt":"2009-01-15T20:00:00","slug":"gerybine-prostatos-hiperplazija-diagnostika-ir-ankstyvos-jos-stadijos-gydymas-augaliniu-vaistu-prostamol-uno","status":"publish","type":"post","link":"https:\/\/www.pasveik.lt\/lt\/naujausi-medicinos-straipsniai\/gerybine-prostatos-hiperplazija-diagnostika-ir-ankstyvos-jos-stadijos-gydymas-augaliniu-vaistu-prostamol-uno\/13103\/","title":{"rendered":"Gerybin\u0117 prostatos hiperplazija: diagnostika ir ankstyvos jos stadijos gydymas augaliniu vaistu Prostamol Uno"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\"><em><o:p><\/o:p><\/em><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><strong><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Gyd. Giedr\u0117 Grigien\u0117<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><strong><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Vilniaus Universitetas<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Sakoma, kad prostata &ndash; antroji vyr\u0173 \u0161irdis. Nuo prostatos priklauso vyro gyvybingumas, darbingumas, lytin\u0117 potencija. Ta\u010diau metams b\u0117gant d\u0117l testosterono ir dihidrotestosterono gamybos poky\u010di\u0173 prostatos audinys kinta, i\u0161ve\u0161i. Toks nepiktybinis prostatos liaukos padid\u0117jimas vadinamas gerybine<o:p><\/o:p><\/span> <span lang=\"LT\"><font size=\"2\">prostatos hiperplazija (GPH), ji pasirei\u0161kia \u012fvairiais \u0161lapinimosi sutrikimais. Tai yra normalus su am\u017eiumi susij\u0119s procesas &ndash; beveik 50 proc. vyresni\u0173 60 met\u0173 am\u017eiaus vyr\u0173 serga GPH, tuo tarpu tarp sulaukusi\u0173 85 met\u0173 GPH nustatoma per 90 proc. vyr\u0173 (1, 2). Neretai GPH diagnozuojama ir jaunesniems vyrams (2).<\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Nors su gerybiniu prostatos padid\u0117jimu susij\u0119 simptomai vargina tik apie 50 proc. sergan\u010di\u0173j\u0173, ta\u010diau tai sudaro apie 30 mln. vyr\u0173 visame pasaulyje (1). Da\u017eniausiai \u0161lapinimosi sutrikimai atsiranda palaipsniui &ndash; vyrai pastebi, kad susilpn\u0117ja \u0161lapimo srov\u0117, prad\u0117ti \u0161lapintis tampa sunkiau, nakt\u012f tenka net kelet\u0105 kart\u0173 keltis \u0161lapintis. Tokiems vyrams gali kartotis \u0161lapimo tak\u0173 infekcijos, vystytis inkst\u0173 funkcijos nepakankamumas, \u0161lapimo tak\u0173 infekcijos, \u0161lapimo p\u016bsl\u0117s akmenys (3).<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">GPH b\u016bdinga ir stromos, ir epitelio l\u0105steli\u0173 hiperplazija, ypa\u010d apie \u0161lapl\u0119 esan\u010dioje prostatos dalyje. Hiperplazijos \u017eidiniams did\u0117jant ir spaud\u017eiant \u0161lapl\u0119, sutrinka \u0161lapimo nutek\u0117jimas. GPH sukeliami \u0161lapinimosi sutrikimai yra susij\u0119 ir su prostatos stromoje, \u0161lapl\u0117je ir \u0161lapimo p\u016bsl\u0117s kaklelyje esan\u010di\u0173 alfa 1 adrenoreceptori\u0173 dirginimu.<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">GPH klinikiniai simptomai<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Da\u017eniausiai vyrus varginantys simptomai yra \u0161ie (1):<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&bull; \u0160lapinimosi da\u017enumas<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o Da\u017enesnis noras \u0161lapintis dien\u0105 ir nakt\u012f, \u0161lapinimasis ma\u017eais kiekiais kiekvien\u0105 kart\u0105<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o Pertraukiamas miegas d\u0117l poreikio pasi\u0161lapinti nakties metu<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&bull; \u0160lapinimosi staigumas<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o Staigus noras \u0161lapintis<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o \u0160lapimo nelaikymo poj\u016btis<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&bull; \u0160lapimo srov\u0117s silpnumas<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o Nenuolatin\u0117, pertraukiama, silpna \u0161lapimo srov\u0117<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o Sunku prad\u0117ti \u0161lapintis<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o Atsis\u0117dimo ar stov\u0117jimo prie klozeto poreikis, norint prad\u0117ti \u0161lapintis<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&bull; Nepakankamas \u0161lapimo p\u016bsl\u0117s i\u0161tu\u0161tinimas<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">o Nevisi\u0161kai i\u0161tu\u0161tintos \u0161lapimo p\u016bsl\u0117s poj\u016btis<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&bull; \u012esitempimas &ndash; poreikis \u012fsitempti, norint prad\u0117ti ir t\u0119sti \u0161lapinim\u0105si siekiant visi\u0161kai i\u0161tu\u0161tinti \u0161lapimo<o:p><\/o:p><\/span> <span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">p\u016bsl\u0119<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&bull; Silpn\u0117jantis \u0161lapimo srov\u0117s stiprumas<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&bull; \u0160lapimo la\u0161\u0117jimas<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"color: #00baf4; font-family: Arial; mso-ansi-language: LT\"><font size=\"3\">&nbsp;<\/font><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"color: #00baf4; font-family: Arial; mso-ansi-language: LT\"><font size=\"3\"><o:p><\/o:p><\/font><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><strong><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Diagnostika<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><i><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Anamnez\u0117. <\/span><\/i><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Pastaruoju metu klinikiniams simptomams \u012fvertinti si\u016bloma naudoti Amerikos urolog\u0173 asociacijos simptom\u0173 indeks\u0105 (4) arba Tarptautin\u0119 prostatos simptom\u0173 skal\u0119 <i>(1 lentel\u0117)<\/i>. TPSS &ndash; tai septyni klausimai apie \u0161lapinimosi b\u016bkl\u0119, \u012f kuriuos atsak\u0119s pacientas surenka tam tikr\u0105 bal\u0173 sum\u0105, parodan\u010di\u0105 simptom\u0173 sunkum\u0105 (5):<o:p><\/o:p><\/span><\/p>\n<ul style=\"margin-top: 0cm\" type=\"disc\">\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; color: black; text-align: justify; mso-layout-grid-align: none; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">nuo 0 iki 7 bal\u0173 &ndash; lengvi sutrikimai,<o:p><\/o:p><\/span><\/li>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; color: black; text-align: justify; mso-layout-grid-align: none; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">nuo 8 iki 18 bal\u0173 &ndash; vidutinio sunkumo sutrikimai,<o:p><\/o:p><\/span><\/li>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; color: black; text-align: justify; mso-layout-grid-align: none; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">nuo 19 iki 35 bal\u0173 &ndash; sunk\u016bs sutrikimai.<o:p><\/o:p><\/span><\/li>\n<\/ul>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><i><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Rektalinis tyrimas. <\/span><\/i><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Padid\u0117jusi prostate ap\u010diuopiama pir\u0161tu pro tiesi\u0105j\u0105 \u017earn\u0105. Taip nustatomas apytikris prostatos dydis, forma, pavir\u0161ius, konsistencija. Taip pat svarb\u016bs <i>laboratoriniai tyrimai <\/i>&ndash; bendras \u0161lapimo tyrimas (infekcijos, kraujui \u0161lapime \u012fvertinti), kraujo tyrimas (kreatinino, \u0161lapalo<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">koncentracija kraujyje inkst\u0173 funkcijai \u012fvertinti), prostatos specifinis antigenas (PSA). <i>Ultragarsinis tyrimas. <\/i>Echoskopu nustatomas prostatos t\u016bris, liekamojo \u0161lapimo kiekis p\u016bsl\u0117je pasi\u0161lapinus, inkst\u0173 b\u016bkl\u0117.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\"><o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><strong><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Gydymas<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Daug met\u0173 \u012fprastinis prostatos hiperplazijos gydymo b\u016bdas buvo chirurginis. Ta\u010diau dabar, kai liga ankstyvos stadijos, vis da\u017eniau gydoma medikamentais, siekiant ne tik palengvinti simptomus, bet ir apsaugoti ligonius nuo galim\u0173 prostatos hiperplazijos komplikacij\u0173 ateityje, pavyzd\u017eiui, \u016bminio \u0161lapimo susilaikymo ar operacijos.<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Augaliniai preparatai<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Esant lengvam \u0161lapinimosi sutrikimui, skiriami augaliniai preparatai ir j\u0173 deriniai (6). Vaistai, i\u0161gauti i\u0161 augal\u0173 ekstrakt\u0173, pla\u010diai vartojami visame pasaulyje. Amerikoje per metus jiems i\u0161leid\u017eiama apie 3,65 milijardo doleri\u0173, Pranc\u016bzijoje ir Vokietijoje augal\u0173 ekstraktai sudaro apie 50 proc. vis\u0173 i\u0161ra\u0161om\u0173 vaist\u0173 GPH gydyti (1). Augaliniai preparatai patraukl\u016bs nat\u016braliomis augal\u0173 gydomosiomis savyb\u0117mis ir itin retai sukeliamu nepageidaujamu poveikiu. J\u0173 poveikis n\u0117ra stiprus, tod\u0117l rekomenduojami ilgi gydymo kursai (6).<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Kiekviena med\u017eiaga turi vien\u0105 ar daugiau veikimo b\u016bd\u0173 &ndash; augaliniai preparatai veikia prostat\u0105, ma\u017eina \u0161lapimo tak\u0173 dirginim\u0105, mal\u0161ina u\u017edegim\u0105. Didel\u0117s dalies augalini\u0173 preparat\u0173 vartojan\u010di\u0173 vyr\u0173 b\u016bkl\u0117 pager\u0117ja. Moksliniai duomenys, pagrind\u017eiantys \u0161i\u0173 preparat\u0173 veiksmingum\u0105, dar tebekaupiami.<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Pradini\u0173 stadij\u0173 GPH gydymas<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><i><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\"><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a><o:p><\/o:p><\/span><\/i><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Prostatos padid\u0117jimas priklauso nuo androgen\u0173 dihidrotestosterono (DHT). Prostatos liaukoje fermentai 5 alfa reduktaz\u0117s metabolizuoja cirkuliuojant\u012f testosteron\u0105 \u012f DHT. DHT prisijungia prie androgen\u0173 receptori\u0173 l\u0105stel\u0117s branduolyje, skatina l\u0105steli\u0173 proliferacij\u0105 ir sukelia GPH.<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Nat\u016brali\u0173 5 alfa reduktaz\u0117s inhibitori\u0173 yra suk\u016brusi ir gamta. \u0160iuo metu klinikin\u0117je praktikoje bene da\u017eniausiai vartojamas i\u0161 palm\u0117s <i>Sabal serrulata <\/i>vaisi\u0173 gautas ekstraktas (<i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a><\/i>)<i>, <\/i>slopinantis 5 alfa reduktaz\u0119 ir DHT jungim\u0105si prie androgen\u0173 receptori\u0173. Jis yra vienas populiariausi\u0173 augalini\u0173 vaist\u0173 GPH gydyti. Veikliosios sudedamosios dalys &ndash; riebal\u0173 r\u016bg\u0161tys, fitosteroliai ir alkoholiai. Sabalpalmi\u0173 ekstrakto poveikis vertinamas kaip antiandrogeninis<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\"><span style=\"mso-spacerun: yes\">&nbsp;<\/span>5). \u0160is ekstraktas blokuoja DHT prisijungim\u0105 prie prostatos stromos l\u0105steli\u0173 citoplazmoje esan\u010di\u0173 androgenini\u0173 receptori\u0173, be to, jis slopina 5 alfa reduktaz\u0117s aktyvum\u0105. Taip pat prostatos augimas slopinamas ir kitais b\u016bdais: slopinant 5 lipooksigenaz\u0117s poveik\u012f gaunamas u\u017edegim\u0105 slopinantis poveikis, slopinama prostatos epitelio proliferacija, ma\u017einamas prostatos audinio paburkimas (7).<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Neseniai preparato veiksmingumas tirtas Lenkijoje vykusio daugiacentrio tyrimo metu (8). Tyrime dalyvavo daugiau kaip 8000 vyr\u0173, visus juos vargino apatini\u0173 \u0161lapimo tak\u0173 simptomai, b\u016bdingi GPH. Gydymo <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a> <\/i>veiksmingumas ir saugumas vertintas remiantis Tarptautine prostatos simptom\u0173 skale, gyvenimo kokyb\u0117s indeksu (skal\u0117 nuo 0 (liga neturi \u012ftakos gyvenimo kokybei) iki 6 (maksimalus neigiamas poveikis gyvenimo kokybei)) ir \u0161lapinimosi dien\u0105 ir nakt\u012f da\u017eniu. <i>Prostamol<o:p><\/o:p><\/i><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><i><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">Uno <\/span><\/i><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">veiksmingum\u0105 ir saugum\u0105 vertino urologai trij\u0173 apsilankym\u0173 metu. Pirmo vizito metu 19 proc. Pacient\u0173 teig\u0117, kad j\u0173 simptomai yra lengvi, 60 proc. &ndash; vidutinio sunkumo ir 21 proc. &ndash;<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">sunk\u016bs. Gyvenimo kokyb\u0117s vertinimas buvo vos 4,02. Skyrus <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a><\/i>, 86 proc. pacient\u0173 gydymo veiksmingum\u0105 \u012fvertino kaip ger\u0105 ar labai ger\u0105. 47&ndash;56 met\u0173 am\u017eiaus grup\u0117je \u0161is rodiklis buvo<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; font-family: Arial; mso-ansi-language: LT\">net 97 proc. Tre\u010dio vizito metu savo simptomus kaip nedidelius \u012fvardino jau<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">73 proc. vis\u0173 <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a> <\/i>vartojusi\u0173 pacient\u0173 (palyginti su 19 proc. Tyrimo prad\u017eioje). Po dviej\u0173 m\u0117nesi\u0173 gydymo ligoni\u0173 gyvenimo kokyb\u0117 pager\u0117jo 63 proc., o 90 proc. tyrimo dalyvi\u0173 i\u0161rei\u0161k\u0117 nor\u0105 toliau gydytis <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a><\/i>. Nepageidaujamas poveikis siek\u0117 1 proc.,<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">visoje didesn\u0117je nei 8000 pacient\u0173 populiacijoje nebuvo n\u0117 vieno prane\u0161imo apie sutrikusi\u0105 lytin\u0119 funkcij\u0105.<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Tyrimo metu nustatyta, kad <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a> <\/i>efektyviai gydo GPH sukeltus apatini\u0173 \u0161lapimo tak\u0173 simptomus. Preparatas pagerino gyvenimo kokyb\u0119, jo vartojant nenukent\u0117jo lytin\u0117 funkcija.<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Pager\u0117jusi gyvenimo kokyb\u0117 i\u0161liko viso steb\u0117jimo metu. Svarbiausia &ndash; \u0161iuo klausimu sutapo ir pacient\u0173, ir gydytoj\u0173 nuomon\u0117. Pacientai gerai toleravo <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a> <\/i>&ndash; tyrimas patvirtino, kad tai yra saugus vaistas, tinkamas ilg\u0105 laik\u0105 gydyti GPH.<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">V\u0117lesni\u0173 stadij\u0173 GPH gydymas<o:p><\/o:p><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">GPH progresuojant vien augalini\u0173 preparat\u0173 nebepakanka. Nusta\u010dius padid\u0117jusi\u0105 prostat\u0105 bei vidutinio sunkumo ir sunkius \u0161lapinimosi simptomus, skiriama 5 alfa reduktaz\u0117s inhibitori\u0173 ir uroselektyvi\u0173<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">alfa 1 adrenoreceptori\u0173 blokatori\u0173 (pvz., tamsulosino (<i><a href=\"https:\/\/pasveik.lt\/vaistai\/<a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/-\/9614\">flosin<\/a>\/9848&#8243;>Flosin<\/a><\/i>)).<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Kai medikamentinis gydymas nepakankamai veiksmingas, da\u017eniausiai atliekama chirurginio GPH gydymo &bdquo;auksiniu&ldquo; standartu laikoma transuretralin\u0117 prostatos rezekcija (TURP).<o:p><\/o:p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><b><span lang=\"LT\" style=\"font-family: Arial; mso-ansi-language: LT\"><font size=\"3\">&nbsp;<o:p><\/o:p><\/font><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><strong><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">Apibendrinimas<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\">&nbsp;<\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; text-align: justify; mso-layout-grid-align: none\"><span lang=\"LT\" style=\"font-size: 10pt; color: black; font-family: Arial; mso-ansi-language: LT\">GPH serga daugelis vyresnio am\u017eiaus vyr\u0173. \u0160i l\u0117tin\u0117 liga sukelia \u012fvairi\u0173 \u0161lapinimosi sutrikim\u0173, tod\u0117l labai svarbu prostatos hiperplazijos gydymu susir\u016bpinti, kai liga dar pradini\u0173 stadij\u0173, kai dar veiksmingas ilgalaikis gydymas augaliniais preparatais. Vienas j\u0173 &ndash; <i><a href=\"https:\/\/pasveik.lt\/lt\/vaistai\/prostamol-uno\/6761\">Prostamol Uno<\/a><\/i>, vartojamas po vien\u0105 kapsul\u0119 per dien\u0105 ne ma\u017eiau nei 3&ndash;6 m\u0117nesius (geriau 6&ndash;12 m\u0117nesi\u0173), pagerina \u0161lapimo nutek\u0117jim\u0105, sustiprina \u0161lapimo srov\u0119, re\u010diau reikia keltis nakt\u012f, taip pat pagerina ir su liga susijusi\u0105 gyvenimo kokyb\u0119 (8).<\/span><b><span lang=\"LT\" style=\"font-family: Arial; mso-ansi-language: LT; mso-bidi-font-size: 30.0pt\"><o:p><\/o:p><\/span><\/b><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Gyd. Giedr\u0117 Grigien\u0117 Vilniaus Universitetas &nbsp; Sakoma, kad prostata &ndash; antroji vyr\u0173 \u0161irdis. Nuo prostatos priklauso vyro gyvybingumas, darbingumas, lytin\u0117 potencija. Ta\u010diau metams b\u0117gant d\u0117l testosterono ir dihidrotestosterono gamybos poky\u010di\u0173 prostatos audinys kinta, i\u0161ve\u0161i. Toks nepiktybinis prostatos liaukos padid\u0117jimas vadinamas gerybine prostatos hiperplazija (GPH), ji pasirei\u0161kia \u012fvairiais \u0161lapinimosi sutrikimais. Tai yra normalus su am\u017eiumi&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[2,259,898,100,893,138,727],"site":[],"post_item_type":[27345],"class_list":["post-13103","post","type-post","status-publish","format-standard","hentry","tag-infekcijos","tag-preparatai","tag-prostamol","tag-prostata","tag-pusles","tag-vaistai","tag-veiksmingas"],"acf":{"post_sites":false},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/13103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/comments?post=13103"}],"version-history":[{"count":0,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/13103\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media?parent=13103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/categories?post=13103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/tags?post=13103"},{"taxonomy":"site","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/site?post=13103"},{"taxonomy":"post_item_type","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/post_item_type?post=13103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}